|
Volumn 47, Issue 5, 1998, Pages 351-358
|
Abciximab-induced thrombocytopenia in the treatment of acute coronary syndromes by angioplasty;Thrombopenie sous abciximab dans le traitement des syndromes coronariens aigus par angioplastie
a
a
Lilly France
(France)
|
Author keywords
Abciximab; Coronary angioplasty; Thrombocytopenia
|
Indexed keywords
ABCIXIMAB;
ACETYLSALICYLIC ACID;
HEPARIN;
ANTITHROMBOCYTIC AGENT;
IMMUNOGLOBULIN F(AB) FRAGMENT;
MONOCLONAL ANTIBODY;
PLACEBO;
ANGIOPLASTY;
ARTICLE;
DISEASE COURSE;
DISEASE SEVERITY;
DRUG MECHANISM;
HEART MUSCLE ISCHEMIA;
HUMAN;
MAJOR CLINICAL STUDY;
PRACTICE GUIDELINE;
PROVOCATION TEST;
THROMBOCYTE COUNT;
THROMBOCYTOPENIA;
TREATMENT OUTCOME;
ACUTE DISEASE;
CHEMICALLY INDUCED DISORDER;
CLINICAL TRIAL;
CORONARY ARTERY DISEASE;
RANDOMIZED CONTROLLED TRIAL;
TRANSLUMINAL CORONARY ANGIOPLASTY;
ACUTE DISEASE;
ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY;
ANTIBODIES, MONOCLONAL;
CORONARY DISEASE;
HUMANS;
IMMUNOGLOBULIN FAB FRAGMENTS;
MYOCARDIAL ISCHEMIA;
PLACEBOS;
PLATELET AGGREGATION INHIBITORS;
THROMBOCYTOPENIA;
|
EID: 0032058725
PISSN: 00033928
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (11)
|
References (30)
|